Martin Grigorian

Financial Analyst at Knight Therapeutics - Montreal, Quebec, CA

Martin Grigorian's Colleagues at Knight Therapeutics
Sofia Boloque

HRIS & Talent Acquisition Analyst

Contact Sofia Boloque

Javier Souza

Senior Supply Chain Specialist Operativa Canadá

Contact Javier Souza

Fabiana Bianchi

Gerente Regional de Aseguramiento de Calidad

Contact Fabiana Bianchi

Olga Garcia

Regional Marketing Leader LatAm

Contact Olga Garcia

View All Martin Grigorian's Colleagues
Martin Grigorian's Contact Details
HQ
(514) 484-4483
Location
Montevideo,Montevideo Department,Uruguay
Company
Knight Therapeutics
Martin Grigorian's Company Details
Knight Therapeutics logo, Knight Therapeutics contact details

Knight Therapeutics

Montreal, Quebec, CA • 817 Employees
Major Drugs

Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Headquartered in Montreal, Knight has operations in Canada and in 10 countries in Latin America and has over 700 employees globally. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD.

Prescription Pharmaceuticals Latin American Pharmaceutical Company Pharmaceutical Marketing Pharmaceutical Commercialization Pharmaceutical Licensing Pharmaceutical Distribution Specialty Pharmaceutical
Details about Knight Therapeutics
Frequently Asked Questions about Martin Grigorian
Martin Grigorian currently works for Knight Therapeutics.
Martin Grigorian's role at Knight Therapeutics is Financial Analyst.
Martin Grigorian's email address is ***@gud-knight.com. To view Martin Grigorian's full email address, please signup to ConnectPlex.
Martin Grigorian works in the Major Drugs industry.
Martin Grigorian's colleagues at Knight Therapeutics are Sofia Boloque, Javier Souza, Maria Labrador, Marta Quijano, Alejandro Diaz, Fabiana Bianchi, Olga Garcia and others.
Martin Grigorian's phone number is (514) 484-4483
See more information about Martin Grigorian